| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-06 |